English
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  1. Home
  2. Stocks
  3. Emcure Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Emcure Pharmaceuticals

    Large Cap
    ₹1,493.6
    +52 (3.61%)
    18 September, 2024 08:24 BSE: 544210 NSE: EMCUREISIN: INE168P01015

    Start SIP in Emcure Pharmaceuticals

    Start SIP

    Emcure Pharmaceuticals Performance

    Day Range

    • Low 1,439
    • High 1,520
    ₹ 1,493

    52 Week Range

    • Low 1,225
    • High 1,520
    ₹ 1,493
    • Open Price1,455
    • Previous Close1,442
    • Volume383720

    Emcure Pharmaceuticals Share Price

    • Over 1 Month +18.66%
    • Over 3 Month +48.17%
    • Over 6 Month +48.17%
    • Over 1 Year +48.17%

    Emcure Pharmaceuticals Key Statistics

    P/E Ratio
    PEG Ratio
    Market Cap Cr
    Price to Book Ratio 9
    EPS 8.9
    Dividend 0
    Relative Strength Index 70.12
    Money Flow Index 77.05
    MACD Signal 22.3
    Average True Range 47.34
    Emcure Pharmaceuticals Financials
    IndicatorJun 2024Mar 2024Jun 2023
    Oper Rev Qtr Cr 970903837
    Operating Expenses Qtr Cr 855796725
    Operating Profit Qtr Cr 115106111
    Depreciation Qtr Cr 553939
    Interest Qtr Cr 385646
    Tax Qtr Cr 15612
    Net Profit Qtr Cr 402936
    IndicatorMar 2023
    Total Revenue Annual Cr 3,232
    Operating Expenses Annual Cr 2,669
    Operating Profit Annual in Cr 438
    Depreciation Cr 179
    Interest Annual Cr 167
    Tax Annual Cr 52
    Net Profit Annual Cr 160
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 505
    Cash from Investing Activity Annual Cr -270
    Cash from Financing Annual Activity Cr -55
    Net Cash Flow Annual Cr 180
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 1,842
    Fixed Assets Annual Cr 1,686
    Total Non Current Assets Annual Cr 2,476
    Total Current Assets Annual Cr 2,140
    Total Assets Annual Cr 4,616
    IndicatorMar 2023
    Book Value Per Share Annual Rs 102
    ROE Annual % 9
    ROCE Annual % 15
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 18
    IndicatorJun 2024Mar 2024Jun 2023
    Oper Rev Qtr Cr 1,8151,7711,556
    Operating Expenses Qtr Cr 1,4791,4601,261
    Operating Profit Qtr Cr 336311296
    Depreciation Qtr Cr 946552
    Interest Qtr Cr 599167
    Tax Qtr Cr 554650
    Net Profit Qtr Cr 144115130
    IndicatorMar 2023
    Total Revenue Annual Cr 6,032
    Operating Expenses Annual Cr 4,805
    Operating Profit Annual in Cr 1,181
    Depreciation Cr 260
    Interest Annual Cr 214
    Tax Annual Cr 185
    Net Profit Annual Cr 532
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 747
    Cash from Investing Activity Annual Cr -468
    Cash from Financing Annual Activity Cr -145
    Net Cash Flow Annual Cr 134
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 2,501
    Fixed Assets Annual Cr 2,341
    Total Non Current Assets Annual Cr 2,837
    Total Current Assets Annual Cr 3,836
    Total Assets Annual Cr 6,673
    IndicatorMar 2023
    Book Value Per Share Annual Rs 147
    ROE Annual % 21
    ROCE Annual % 26
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 20
    Invest in Emcure Pharmaceuticals

    Emcure Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹1,493.6
    +52 (3.61%)
    pointer
    • Bullish Moving Average
    • ___
    • 9
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹1,402.50
    • 50 Day
    • ₹
    • 100 Day
    • ₹
    • 200 Day
    • ₹
    • 20 Day
    • ₹1,404.51
    • 50 Day
    • ₹
    • 100 Day
    • ₹
    • 200 Day
    • ₹

    Emcure Pharmaceuticals Resistance and Support

    PIVOT
    ₹1,484.29
    Resistance
    First Resistance 1,529.32
    Second Resistance 1,565.03
    Third Resistance 1,610.07
    RSI 70.12
    MFI 77.05
    MACD Single Line 22.30
    MACD 29.52
    Support
    First Support 1,448.57
    Second Support 1,403.53
    Third Supoort 1,367.82

    Emcure Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 403,880 16,538,886 40.95
    Week 210,085 10,527,369 50.11
    1 Month 232,657 12,184,221 52.37
    6 Month 230,207 13,690,389 59.47

    Emcure Pharmaceuticals Result Highlights

    Emcure Pharmaceuticals Synopsis

    NSE-Medical-Supplies

    Emcure Pharmaceutica is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3107.09 Cr. and Equity Capital is Rs. 180.85 Cr. for the Year ended 31/03/2023. Emcure Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/04/1981 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U24231PN1981PLC024251 and registration number is 024251.
    Market Cap 28,244
    Sales 1,873
    Shares in Float 4.16
    No of funds
    Yield
    Book Value 14.67
    U/D Vol ratio 0.4
    LTDebt / Equity 33
    Alpha 0.14
    Beta 0.82

    Emcure Pharmaceuticals Shareholding Pattern

    Owner Name

    Emcure Pharmaceuticals Management

    Name Designation
    Mr. Berjis Minoo Desai Chairman & Non-Exe.Director
    Mr. Satish Ramanlal Mehta Managing Director & CEO
    Mr. Sunil Rajanikant Mehta Whole Time Director
    Ms. Namita Vikas Thapar Whole Time Director
    Mr. Samit Satish Mehta Whole Time Director
    Mr. Mukund Keshao Gurjar Whole Time Director
    Mr. Samonnoi Sajani Banerjee Director
    Mr. Palamadai Sundararajan Jayakumar Director
    Mr. Vijay Keshav Gokhale Director
    Ms. Vidya Rajiv Yeravdekar Director
    Mr. Shailesh Kripalu Ayyangar Director

    Emcure Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Emcure Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-08-13 Quarterly Results

    Emcure Pharmaceuticals MF Shareholding

    Name Amount(cr)
    HDFC Balanced Advantage Fund Growth 95,391
    Nippon India Multi Cap Fund - Growth 38,115
    Aditya Birla Sun Life ELSS Tax Saver Pyt of Inc Dis cum Cap Wdrl 16,831
    HDFC Manufacturing Fund Regular Growth 13,278
    Axis Flexi Cap Fund Regular Growth 13,111

    Emcure Pharmaceuticals FAQs

    What is Share Price of Emcure Pharmaceuticals ?

    Emcure Pharmaceuticals share price is ₹1,493 As on 18 September, 2024 | 08:10

    What is the Market Cap of Emcure Pharmaceuticals ?

    The Market Cap of Emcure Pharmaceuticals is ₹28243.7 Cr As on 18 September, 2024 | 08:10

    What is the P/E ratio of Emcure Pharmaceuticals ?

    The P/E ratio of Emcure Pharmaceuticals is As on 18 September, 2024 | 08:10

    What is the PB ratio of Emcure Pharmaceuticals ?

    The PB ratio of Emcure Pharmaceuticals is 9 As on 18 September, 2024 | 08:10

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.